The role of sympathetic activation in sole SGLT-1 inhibitor and dual SGLT-1/2 inhibitor induced cardiorenal protection.

Project Details

StatusActive
Effective start/end date8/01/2431/12/24

Funding

  • Royal Perth Hospital Medical Research Foundation: A$20,000.00